Teva Pharmaceutical Beats Estimates As Top Line Rises 12% Amid N. America Strength
Rate:
21,061 ratings
Views: 251
From: TradeTheTrend
Added: 16 years ago · 0:42 · 480p
Jerusalem-based drugmaker Teva Pharmaceutical (NASDAQ:TEVA) reported Q2 EPS of $1.08, topping consensus estimates of ...
Comments
No comments yet.